University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 16 of 24
The Snack Study: The Feasibility of Changing Night-time Food Choices to Improve Glucose Tolerance in Pregnancy
NCT02634593
Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
NCT02780583
Genetic Evaluation for Medication Selection (GEMS) Study
NCT03736057
Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
NCT02538341
A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity
NCT02787668
Smoking Cessation Tailored to Rural Young Adult African American Men:
NCT03808714
Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study
NCT02794662
Effects of Diet on Brain Processing
NCT02835820
A Study of INFUSE Bone Graft (BMP-2) in the Treatment of Tibial Pseudarthrosis in Neurofibromatosis Type 1 (NF1)
NCT02718131
Outpatient Foley For Starting Induction of Labor at TErm
NCT02756689
To Compare Free Gingival Grafts and Connective Tissue Grafts Around Implants With Lack of Keratinized Mucosa
NCT03338686
Nocturnal Hypertension and Non-Dipping Blood Pressure
NCT03128177
Prospective Pilot Clinical Trial of Azithromycin Treatment In Respiratory Syncytial Virus (RSV)- Induced Respiratory Failure In Children
NCT02707523
Usefulness of A Scope Guide Assisted Colonoscopy Versus Conventional Colonoscopy
NCT02739893
Pragmatic Airway Resuscitation Trial
NCT02419573
Prospective Evaluation of Idiopathic Pancreatitis: Role of Endoscopic Ultrasonography
NCT00609726
Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants
NCT02799875
ENABLE CHF-PC (Comprehensive Heartcare For Patients and Caregivers)
NCT02505425
A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer
NCT02429843
Natural History of Rett Syndrome & Related Disorders
NCT02738281
Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography
NCT02995980
Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)
NCT02605616
Comparing Bupivacaine, Lidocaine, and a Combination of Bupivacaine and Lidocaine for Labor Epidural Activation
NCT03103100
Dietary Prevention of Photodamage in Skin With Grapes
NCT02760160
Overcoming TWEAK Signaling to Restore Muscle and Mobility After Joint Replacement
NCT02628795
CARE Trial: Comparing Different Levels of Calorie Reduction for Weight Loss
NCT02736669
Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma
NCT02541903
Real-World Evaluation of the Effect of Jublia on Nail Polish
NCT03022916
Evaluating the Efficacy and Compatibility of Efinaconazole 10% Solution (Jublia) for the Treatment of Toenail Onychomycosis in Patients Wearing Toenail Polish Compared to Those Without Polish
NCT03110029
Study Evaluating the Effect of Jublia on Dermatophytomas
NCT03098615
Blue Light Photodynamic Therapy Treatment for Distal and Lateral Subungual Toenail Onychomycosis
NCT03022903
Impact of Lowering Phosphate Additive Intake on Metabolism and Cardiovascular Health in Community-Living Adults
NCT02620449
Home-Based Pulmonary Rehab for Patients With Pulmonary Fibrosis
NCT02600689
Mechanisms of Refractory Hypertension (Reserpine)
NCT03223272
The Deep South IVR-based Active Lifestyle Study
NCT02627235
Utility of Ultrasound in Identification of Midline and Placement of Epidural in Severely Obese Parturients
NCT03100968
The Use of an Open Label Placebo to Treat Cancer Related Fatigue in Cancer Survivors
NCT02522988
Chronic Hypertension and Pregnancy (CHAP) Project
NCT02299414
Breast VCEUS to Evaluate Early Response to Neoadjuvant Chemotherapy
NCT01817374
TOPIC Trial for COPD
NCT02135432
Psilocybin-facilitated Treatment for Cocaine Use
NCT02037126
Influence of Ambient Temperature on Office Behaviors
NCT02507310
The Role of Protein in Regulating Ad Libitum Energy Intake in Humans
NCT02613065
Study of Regorafenib for Urothelial Cancer Following Chemotherapy (UAB 1477)
NCT02459119
Gaming Console Home-Based Exercise for Adults With Cystic Fibrosis
NCT02277860
miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
NCT02418195
Community Influences Transitions in Youth Health (CITY) Health II - Center for the Study of Community Health
NCT04320186
Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula
NCT02414204
Interactive Videoconferencing in the Provision of Remote Peritoneal Dialysis
NCT02428803
University of Alabama at Birmingham (UAB) Adult CBD Program
NCT02700412
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.